adisinsight.springer.com
- Domain
- adisinsight.springer.com
- Category
- Uncategorized
- Publisher
- springer.com
Top References from adisinsight.springer.com
| Score | Article | Date | Citations |
|---|---|---|---|
| 5.8 |
BMB 105https://adisinsight.springer.com/drugs/800085290 |
N/A | 2 |
| 5.8 |
SVN 015https://adisinsight.springer.com/drugs/800088022 |
N/A | 2 |
| 5.8 |
EXV 801https://adisinsight.springer.com/drugs/800085769 |
N/A | 2 |
| 5.8 |
CBL 514https://adisinsight.springer.com/drugs/800052104 |
N/A | 2 |
| 5.8 |
Deuterated testosteronehttps://adisinsight.springer.com/drugs/800065467 |
N/A | 2 |
| 5.8 |
Celgene Corporationhttps://adisinsight.springer.com/drugs/800060072 |
N/A | 2 |
| 5.8 |
IRL 757https://adisinsight.springer.com/drugs/800069085 |
N/A | 2 |
| 5.8 |
Oxymetazolinehttps://adisinsight.springer.com/drugs/800086617 |
N/A | 2 |
| 5.8 |
Ondansetron/Pramipexolehttps://adisinsight.springer.com/drugs/800082563 |
N/A | 2 |
| 5.8 |
SB 247853https://adisinsight.springer.com/drugs/800016366 |
N/A | 2 |
| 5.8 |
Biohaven Pharmaceuticalshttps://adisinsight.springer.com/drugs/800056133 |
N/A | 2 |
| 5.8 |
RE 104https://adisinsight.springer.com/drugs/800074379 |
N/A | 2 |
| 5.8 |
Biogen/SAGE Therapeuticshttps://adisinsight.springer.com/drugs/800043382 |
N/A | 2 |
| 2.9 |
Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants With Alzheimer's Disease Dementiahttps://adisinsight.springer.com/trials/700388876 |
N/A | 1 |
| 2.9 |
Robalzotan - AdisInsighthttps://adisinsight.springer.com/drugs/800006370 |
N/A | 1 |
| 2.9 |
Clifutinib besylatehttps://adisinsight.springer.com/drugs/800049376 |
N/A | 1 |
| 2.9 |
Research programme: HDAC6 inhibitors - Celgene - AdisInsighthttps://adisinsight.springer.com/drugs/800030705 |
N/A | 1 |
| 2.9 |
Bermekimab - Janssen Biotech - AdisInsighthttps://adisinsight.springer.com/drugs/800031806?error=cookies_not_supported&code=70acb5de-b171-4695-930b-7f2a76cdc3e9 |
N/A | 1 |
| 2.9 |
SENS 01 - AdisInsighthttps://adisinsight.springer.com/drugs/800072348 |
N/A | 1 |
| 2.9 |
LU 35138https://adisinsight.springer.com/drugs/800014237 |
N/A | 1 |
| 2.9 |
Flortaucipir F 18 - Avid Radiopharmaceuticals - AdisInsighthttps://adisinsight.springer.com/drugs/800039440 |
N/A | 1 |
| 2.9 |
Research programme: antidepressants - Clera - AdisInsighthttps://adisinsight.springer.com/drugs/800020943 |
N/A | 1 |
| 2.9 |
TGFK 09SDhttps://adisinsight.springer.com/drugs/800032503 |
N/A | 1 |
| 2.9 |
Research programme: metabotropic glutamate receptor modulators - Pfizer - AdisInsighthttps://adisinsight.springer.com/drugs/800033300 |
N/A | 1 |
| 2.9 |
Darlifarnibhttps://adisinsight.springer.com/drugs/800062546 |
N/A | 1 |
| 2.9 |
Research programme: CNS disorders therapeutics - Mapreg - AdisInsighthttps://adisinsight.springer.com/drugs/800029181 |
N/A | 1 |
| 2.9 |
Dencatistathttps://adisinsight.springer.com/drugs/800061661 |
N/A | 1 |
| 2.9 |
Talaglumetadhttps://adisinsight.springer.com/drugs/800018821 |
N/A | 1 |
| 2.9 |
Research programme: peptide therapeutics - Psylin Neurosciences - AdisInsighthttps://adisinsight.springer.com/drugs/800030052 |
N/A | 1 |
| 2.9 |
Research programme: CNS disorders therapeutics - Sage Therapeutics - AdisInsighthttps://adisinsight.springer.com/drugs/800035109 |
N/A | 1 |
| 2.9 |
Research programme: serotonin reuptake inhibitors/serotonin 1A receptor antagonists - Pfizer - AdisInsighthttps://adisinsight.springer.com/drugs/800013819 |
N/A | 1 |
| 2.9 |
SDZ 208912https://adisinsight.springer.com/drugs/800000644 |
N/A | 1 |
| 2.9 |
Research programme: antidepressants - Wyeth - AdisInsighthttps://adisinsight.springer.com/drugs/800025888 |
N/A | 1 |
| 2.9 |
Aldoxorubicin - LadRx Corporation - AdisInsighthttps://adisinsight.springer.com/drugs/800025015?error=cookies_not_supported&code=4c61e18b-0855-44f8-a12a-edc5d01ca3c4 |
N/A | 1 |
| 2.9 |
Estianeptine - Tonix Pharmaceuticals Holding Corp - AdisInsighthttps://adisinsight.springer.com/drugs/800073998 |
N/A | 1 |
| 2.9 |
R 102444https://adisinsight.springer.com/drugs/800015510 |
N/A | 1 |
| 2.9 |
AKO 004 - AdisInsighthttps://adisinsight.springer.com/drugs/800064701 |
N/A | 1 |
| 2.9 |
ATHX 105https://adisinsight.springer.com/drugs/800024939 |
N/A | 1 |
| 2.9 |
Lithium cocrystal - Alzamend Neuro - AdisInsighthttps://adisinsight.springer.com/drugs/800058554 |
N/A | 1 |
| 2.9 |
Imofinostathttps://adisinsight.springer.com/drugs/800044855 |
N/A | 1 |
| 2.9 |
Carvotrolinehttps://adisinsight.springer.com/drugs/800001398 |
N/A | 1 |
| 2.9 |
Research programme: depression therapy - Neurologix - AdisInsighthttps://adisinsight.springer.com/drugs/800030770 |
N/A | 1 |
| 2.9 |
Autobahn Therapeuticshttps://adisinsight.springer.com/drugs/800059037 |
N/A | 1 |
| 2.9 |
Research programme: allosteric modulators - Addex Therapeutics - AdisInsighthttps://adisinsight.springer.com/drugs/800024111 |
N/A | 1 |
| 2.9 |
Dabogratinib - TYRA Bioscienceshttps://adisinsight.springer.com/drugs/800066166 |
N/A | 1 |
| 2.9 |
Lenacapavir pacfosacilhttps://adisinsight.springer.com/drugs/800074237 |
N/A | 1 |
| 2.9 |
Linvemastathttps://adisinsight.springer.com/drugs/800074199 |
N/A | 1 |
| 2.9 |
Olorigliflozin - HEC Pharmhttps://adisinsight.springer.com/drugs/800047549 |
N/A | 1 |
| 2.9 |
Research programme: small tryptamine derivatives - Marvel Biosciences - AdisInsighthttps://adisinsight.springer.com/drugs/800075395 |
N/A | 1 |
| 2.9 |
Research programme: peptide therapeutics - SynVax - AdisInsighthttps://adisinsight.springer.com/drugs/800026656 |
N/A | 1 |